320 results on '"Noviello S"'
Search Results
52. O166 ALL-ORAL DUAL THERAPY WITH DACLATASVIR AND ASUNAPREVIR IN PATIENTS WITH HCV GENOTYPE 1B INFECTION: PHASE 3 STUDY RESULTS
53. P1300 EFFICACY AND SAFETY OF DACLATASVIR IN COMBINATION WITH ASUNAPREVIR (DCV+ASV) IN CIRRHOTIC AND NON-CIRRHOTIC PATIENTS WITH HCV GENOTYPE 1B: RESULTS OF THE HALLMARK DUAL STUDY
54. Attualità in tema di antibiotico-profilassi in chirurgia
55. Daclatasvir combined with peginterferon alfa-2a and ribavirin for 12 or 16 weeks in patients with hepatitis C virus genotype 2 or 3 infection: COMMAND GT2/3 study
56. DACLATASVIR COMBINED WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN FOR 12 OR 16 WEEKS IN PATIENTS WITH HCV GENOTYPE 2 OR 3 INFECTION: COMMAND GT2/3 STUDY
57. Efficacia clinica e tollerabilità di Levofloxacina nell’epatopaziente : studio aperto non comparativo
58. Attività batteriostatica e battericida di Levofloxacina e Ciprofloxacina verso uropatogeni determinata mediante MIC, MBC, Time-kill curves e analisi dell’indice di batteriocidia
59. Cefaclor nella faringotonsillite streptococcica in età pediatrica: ruolo della durata della terapia
60. SAT-158 - Factors Impacting SVR12 for Patients with Advanced Cirrhosis Receiving Daclatasvir and Sofosbuvir with Ribavirin in the Ally-1 Study
61. 1418 DACLATASVIR COMBINED WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN FOR 12 OR 16 WEEKS IN PATIENTS WITH HCV GENOTYPE 2 OR 3 INFECTION: COMMAND GT2/3 STUDY
62. Trattamento delle riacutizzazioni infettive di otiti croniche sostenute da stafilococco: studio aperto non comparativo con teicoplanina
63. Efficacy of 6 months treatment with PEG-interferon alpha-2b plus ribavirin (P/R) in patients infected with hepatitis C with genotype 1 of low viral load (G1LVL)
64. Durability of sustained response shown in paediatric patients with chronic hepatitis C who were treated with interferon alfa-2b plus ribavirin
65. Comment on: Outpatient parenteral antibiotic therapy (OPAT) for bone and joint infections: experience from a UK teaching hospital-based service
66. Association of a polymorphism in the indoleamine- 2,3-dioxygenase gene and interferon-α-induced depression in patients with chronic hepatitis C
67. 127 PHOSPHODIESTERASE POLYMORPHISMS MAY BE ASSOCIATED WITH BASELINE THYROID STIMULATING HORMONE (TSH) AND PEGINTERFERON TREATMENT INDUCED HYPOTHYROIDISM IN PATIENTS WITH CHRONIC HEPATITIS C
68. 478 INFECTIONS DURING PEGINTERFERON (PEGIFN)/RIBAVIRIN (RBV) THERAPY ARE ASSOCIATED WITH THE MAGNITUDE OF DECLINE IN THE LYMPHOCYTE COUNT: RESULTS OF THE IDEAL STUDY
69. Sensibilità in vitro dei batteri Gram positivi di maggiore rilevanza clinica, Studio multicentrico
70. Ofloxacina per via topica versus Ceftazidime per via intramuscolare nel trattamento delle infezioni dell'orecchio medio
71. Hepatitis C treatment among racial and ethnic groups in the IDEAL trial
72. 304 METABOLIC SYNDROME (MS) IS A NEGATIVE PREDICTOR OF TREATMENT OUTCOME IN PATIENTS WITH CHRONIC HEPATITIS C: RESULTS FROM THE IDEAL STUDY
73. 2015 GENOME WIDE ANALYSIS OF PATIENTS FROM THE IDEAL STUDY IDENTIFIES A CAUSAL ROLE FOR ITPA GENETIC VARIATION IN RIBAVIRIN-INDUCED HEMOLYTIC ANEMIA
74. Uso locale della gentamicina per il trattamento delle otiti medie croniche riacutizzate
75. Le infezioni delle alte e basse vie respiratorie. Aspetti di microbiologia clinica e di farmcodinamica
76. Imipenem/cilastatina versus ceftazidime nel trattamento delle infezioni batteriche dell'orecchio medio
77. Trattamento delle infezioni batteriche nei pazienti anziani con Imipenem/cilastatina: studio aperto non comparativo
78. Outpatient Parenteral Antibiotic Therapy in the Elderly: an Italian Observational Multicenter Study
79. 126 HEMOGLOBIN DECLINE IS ASSOCIATED WITH SVR AMONG HCV GENOTYPE 1-INFECTED PERSONS TREATED WITH PEGINTERFERON (PEG)/RIBAVIRIN (RBV): ANALYSIS FROM THE IDEAL STUDY
80. In VitroActivity of Tigecycline: MICs, MBCs, Time-Kill Curves and Post-Antibiotic Effect
81. 991 FINAL RESULTS OF THE IDEAL (INDIVIDUALIZED DOSING EFFICACY VERSUS FLAT DOSING TO ASSESS OPTIMAL PEGYLATED INTERFERON THERAPY) PHASE IIIB STUDY
82. 800 SUSTAINED VIROLOGIC RESPONSE TO INTERFERON ALFA-2B PLUS RIBAVIRIN PREDICTS LONG-TERM CLEARANCE OF HCV IN PEDIATRIC PATIENTS AT 5 YEAR FOLLOW-UP
83. Outpatient Parenteral Antibiotic Therapy for Bone and Joint Infections: An Italian Multicenter Study
84. Profilassi con Imipenem in chirurgia addominale. Studio policentrico. Risultati preliminari
85. Attività antibatterica del cefuroxime in colture miste in un modello in vitro di farmacodinamica
86. Esperienze cliniche con Ceftazidime in medicina
87. Efficacia terapeutica di ciprofloxacina orale nei confronti di gentamicina parenterale nelle infezioni da pseudomonas dell'orecchio medio
88. L'impiego della Ciprofloxacina orale nelle infezioni batteriche delle alte vie respiratorie
89. A Pilot Study on Prevention of Catheter-Related Urinary Tract Infections with Fluoroquinolones
90. Antibiotic Prophylaxis in Surgery: An Observational Prospective Study Conducted in a Large Teaching Hospital in Naples
91. Antibiotic Prophylaxis in Hernia Repair and Breast Surgery: A Prospective Randomized Study Comparing Piperacillin/Tazobactam Versus Placebo
92. Clinical Efficacy and Tolerability of Levofloxacin in Patients with Liver Disease: A Prospective, Non Comparative, Observational Study
93. Il cipropfloxacin nel trattamento delle infezioni gastrointestinali
94. Surveillance of Post-Operative Infections and Management of Antibiotic Surgical Prophylaxis in an Italian Region
95. What is the Role of Glycopeptides in Intensive Care?
96. Comparative activity of garenoxacin and other agents by susceptibility and time-kill testing against Staphylococcus aureus, Streptococcus pyogenes and respiratory pathogens
97. Quale Ruolo per i Glicopeptidi in Terapia Intensiva?
98. Modification of Patients’ Endogenous Bacterial Flora During Hospitalization in a Large Teaching Hospital in Naples
99. Cefodizime in Skin Suction Blister Fluid and Serum Following a Single Intravenous or Intramuscular Dose in Adult Patients
100. Bactericidal Activity of Moxifloxacin Compared to Grepafloxacin and Clarithromycin againstStreptococcus pneumoniaeandStreptococcus pyogenesInvestigated Using anIn VitroPharmacodynamic Model
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.